Home Cart Sign in  
Chemical Structure| 865311-47-3 Chemical Structure| 865311-47-3

Structure of Quarfloxin
CAS No.: 865311-47-3

Chemical Structure| 865311-47-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Quarfloxin is a fluoroquinolone derivative with anti-tumor activity that targets and inhibits RNA polymerase I activity by disrupting interactions with ribosomal DNA and G-quadruplex structures.

Synonyms: CX-3543

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Quarfloxin

CAS No. :865311-47-3
Formula : C35H33FN6O3
M.W : 604.67
SMILES Code : O=C(C1=CN2C3=C(C(N4CC(C5=NC=CN=C5)CC4)=C(F)C=C3C1=O)OC6=CC7=CC=CC=C7C=C26)NCC[C@H]8N(C)CCC8
Synonyms :
CX-3543
MDL No. :N/A

Safety of Quarfloxin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Quarfloxin

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00485966 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << PHASE2 WITHDRAWN 2025-06-08 Mayo Clinic, Scottsdale, Arizo... More >>na, 85259, United States|Tower Cancer Research Foundation, Beverly Hills, California, 90211, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, 87131-0001, United States|Oregon Health and Sciences University, Portland, Oregon, 97239-3098, United States|Cancer Therapy and Research Center, San Antonio, Texas, 78229, United States|South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, 78229, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, 54601, United States Less <<
NCT00955292 Advanced Solid Tumors|Lymphoma PHASE1 TERMINATED 2025-12-08 Scottsdale, Arizona, United St... More >>ates|San Antonio, Texas, United States Less <<
NCT00955786 Advanced Solid Tumors|Lymphoma PHASE1 COMPLETED 2025-12-08 Scottsdale, Arizona, 85259, Un... More >>ited States|San Antonio, Texas, 78229, United States Less <<
NCT00780663 Neuroendocrine Tumors|Carcinoi... More >>d Tumor Less << PHASE2 COMPLETED 2025-03-10 Birmingham Hematology and Onco... More >>logy, Birmingham, Alabama, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|Ocala, Florida, 34471, United States|Southern New Mexico Cancer Center, Las Cruces, New Mexico, United States|Texas Oncology, Amarillo, Texas, United States|Texas Oncology, Dallas, Texas, 75246, United States|El Paso Cancer Treatment Center, El Paso, Texas, United States|Cancer Care Centers of South Texas, Kerrville, Texas, United States|UT Health Science Center, San Antonio, Texas, 78229, United States|Tyler Cancer Center, Tyler, Texas, 75702, United States|Virginia Mason Medical Center, Seattle, Washington, 98101, United States|Northwest Cancer Specialists, Vancouver, Washington, 98684, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.65mL

0.33mL

0.17mL

8.27mL

1.65mL

0.83mL

16.54mL

3.31mL

1.65mL

 

Historical Records

Categories